Objective Prospective studies of tea and coffee intake and breast cancer risk have yielded inconsistent results. None of these studies has reported separately on African-American women. We prospectively examined the relation of tea and coffee consumption to risk of breast cancer among 52,062 women aged 21-69 at enrollment in 1995 in the Black Women's Health Study. Methods Dietary intake was assessed in 1995 and 2001 using a validated food frequency questionnaire. Cox proportional hazards models were used to estimate incidence rate ratios (IRR) and 95% confidence intervals (CI), adjusted for breast cancer risk factors.
Introduction
Tea and coffee are sources of flavonoids, lignans, and other polyphenols [1, 2] , which experimental evidence has shown may act as antioxidants, inhibit tumor cell proliferation, and decrease aromatase activity [3] . Coffee and tea are also major sources of caffeine, which may affect estrogen metabolism, although evidence is inconsistent [4] [5] [6] [7] . Two studies reported that higher caffeine or coffee intake was associated with lower estradiol levels [4, 5] , whereas other studies observed a positive [6] or no association [7] .
A meta-analysis reported an inverse association between green tea intake and breast cancer risk, but the results for black tea, the type of tea most commonly consumed in Western populations, were conflicting; an inverse association between black tea and breast cancer was observed among eight case-control studies, whereas among five cohort studies, there was a modest significant increase in risk of breast cancer [8] . Since the publication of the meta-analysis, a prospective study also reported a significant positive association between black tea intake and risk of breast cancer [9] , whereas two others observed no association [10, 11] .
A meta-analysis of coffee consumption observed no overall association among nine cohort studies [12] . Recent prospective studies have also reported no association between intakes of coffee and caffeine and overall risk of breast cancer [9, 10] , but there is some evidence that coffee and caffeine intake may be inversely associated with postmenopausal breast cancer [11] .
The distribution of breast cancer incidence differs between white and black women, with African-American women being more likely to be diagnosed with hormone receptor-negative tumors [13] . Dietary habits differ as well, with African-American women drinking less tea and coffee than white women [14] . No epidemiologic studies have assessed breast cancer risk in relation to tea and coffee intake among African-American women. In a large cohort of African-American women, we prospectively investigated the association between intakes of tea, caffeinated and decaffeinated coffee, and caffeine and risk of breast cancer overall and according to menopausal status and estrogen receptor (ER) and progesterone receptor (PR) status.
Materials and methods

Study population
The Black Women's Health Study (BWHS) is an ongoing prospective follow-up study of black women in the United States. The study was established in 1995 when women from all regions of the United States were enrolled through postal questionnaires [15] . The baseline questionnaire collected information on demographic characteristics, lifestyle factors, and medical history, and usual diet was assessed through a food frequency questionnaire (FFQ). A total of 59,000 women aged 21-69 years whose addresses were judged to be valid have been followed through mailed questionnaires every 2 years. Follow-up questionnaires update exposure information and identify incident cancers and other illnesses. Follow-up has averaged over 80% of the baseline cohort over six questionnaire cycles. We excluded women with a history of breast cancer (n = 732) or other cancer except non-melanoma skin cancer (n = 743) at baseline, as well as participants who had left more than 10 FFQ items blank (n = 1,954) or had missing or implausible energy intake values (\500 or [3,800 kcal) (n = 3,536). After these exclusions, 52,062 women remained in the present analysis.
Assessment of breast cancer
Incident cases of breast cancer were ascertained through self-report on biennial follow-up questionnaires between 1995 and 2007. We asked all women who reported incident breast cancer for written permission to review their medical records. We obtained medical record or cancer registry data for 85% of cases, and of these, 99% were confirmed. We excluded disconfirmed cases. We obtained death certificate data for deaths reported by family members or the U.S. Postal Service. In addition, we searched the National Death Index for all non-respondents and obtained death certificate data for all matches. Information on ER and PR status was obtained through abstraction of medical records and cancer registry data and was available for 59% of cases.
Dietary assessment
We assessed usual diet at baseline in 1995 with a 68-item modified version of the National Cancer Institute-Block FFQ, and in 2001 with an 85-item version [16] . Both FFQs included items for caffeinated coffee, decaffeinated coffee, tea, sugar-sweetened soft drinks, and chocolate candy. On the 2001 FFQ, there was an additional item for diet soft drinks. On both FFQs, the question on tea intake specified both hot and iced tea but did not differentiate between black and green tea; on the 2001 FFQ, the tea item specified consumption of non-herbal tea only. The nine frequency responses ranged from never or \1 serving/month to C2/day for foods and to C6/day for beverages. In 1995, we asked participants to specify a small, medium, or large portion size. A medium portion size was defined for each item (e.g. 1 medium cup), and small and large servings were weighted as 0.5 and 1.5 times a medium serving size, respectively. In 2001, a super-size portion, equivalent to 2 or more times the size of medium, was added. Caffeine intake was estimated by summing the caffeine content from coffee, tea, soft drinks, and chocolate candy. We assumed the caffeine content to be 137 mg per cup of caffeinated coffee, 47 mg per cup of tea, 46 mg per can of cola, and 7 mg per serving of chocolate candy [17] . The FFQ item for soft drinks did not differentiate between caffeinated and decaffeinated soft drinks. Data from the Continuing Survey of Food Intakes by Individuals 1994-1996 indicate that caffeinated soft drinks comprise 75% of soft drink intake among African-American women [18] , and therefore we weighted the caffeine content from soft drink intake reported on our FFQ by 0.75. We adjusted caffeine for total energy intake using the nutrient residual method [19] . The FFQ was validated among 408 participants using a threeday dietary record and up to three 24-h recalls by telephone [20] . Energy-adjusted and deattenuated Pearson correlation coefficients for the FFQ compared with diet records and recalls ranged from 0.5 to 0.8 for total fat, saturated fat, protein, carbohydrate, fiber, calcium, vitamin C, folate, and b-carotene.
Assessment of non-dietary exposures
Information on education, age at menarche, weight at age 18, and height was obtained at baseline in 1995. Data on current weight, vigorous physical activity, smoking status, alcohol intake, parity, age at first birth, oral contraceptive use, menopausal status, age at menopause, and menopausal hormone use were obtained at baseline and have been updated on biennial follow-up questionnaires. Body mass index (BMI) was calculated as weight in kilograms divided by squared height in meters. First-degree family history of breast cancer was ascertained on the 1995 and 1999 questionnaires. Women who reported a hysterectomy but retained one or both ovaries were classified as premenopausal if their current age was less than the 10th percentile of age at natural menopause in the BWHS (43 years), as postmenopausal if their age was greater than the 90th percentile of age at natural menopause in the cohort (56 years), and as uncertain menopausal status between the ages of 43-56 years.
Statistical analysis
Participants contributed person-years from the beginning of follow-up on March 1, 1995, to the diagnosis of breast cancer, death, loss to follow-up, or end of follow-up on March 1, 2007, whichever occurred first. Cox proportional hazards models, jointly stratified by age in one-year intervals and by questionnaire cycle, were used to estimate incidence rate ratios (IRR) and 95% confidence intervals (CI) for risk of breast cancer in relation to intakes of tea, coffee, decaffeinated coffee, and caffeine. To reduce within-person variation and better represent long-term intake, we assessed cumulative average intake [21] . Consumption at baseline was assessed in relation to breast cancer incidence between 1995 and 2001, and the average of 1995 and 2001 consumption was assessed in relation to breast cancer incidence between 2001 and 2007.
Multivariable models were adjusted for energy intake (quintiles), age at menarche (\12, 12-13, C14 years), BMI at age 18 (\20, 20-24, C25 kg/m 2 ), family history of breast cancer (mother or sister), education (B12, 13-15, C16 years), geographic region (Northeast, South, Midwest, West), parity (0, 1, 2, C3 births), age at first birth (\20, 20-24, C25 years), oral contraceptive use (never, use in last 5 years, use C5 years ago), menopausal status (postmenopausal, premenopausal, uncertain), age at menopause (\45, 45-49, C50 years), menopausal hormone use (never, ever use \5 years duration, C5 years duration), vigorous activity (none, 1-4, C5 h/week), smoking status (never, past, current), and alcohol intake (none, 1-3, 4-6, C 7 drinks/week). In the BWHS, BMI at age 18 is more strongly associated with breast cancer risk than is current BMI [22] . When we adjusted for current BMI instead of BMI at age 18, the results were unchanged. Time-varying covariates were updated at the start of each questionnaire cycle (e.g. in 1997 for the 1999 follow-up cycle). Tea, caffeinated coffee, and decaffeinated coffee were mutually adjusted for each other in the multivariable models.
Tests for trend were conducted using the median of each category modeled as a continuous variable. We assessed whether the association between tea, coffee, or caffeine intake and breast cancer risk was modified by menopausal status, age, BMI, or smoking status. Tests for interaction were performed using a likelihood ratio test that compared models with and without interaction terms.
Results
Among 52,062 women at baseline, 22% rarely or never drank tea and 19% drank C1 cup/day, whereas 53% of women rarely or never drank caffeinated coffee and 22% drank C1 cup/day. Among regular coffee drinkers of at least 1 cup per day, median caffeine intake was 312 mg/day, whereas among women who drank less than 1 cup of coffee per day, median caffeine intake was 41 mg/day. The average contribution of coffee, tea, soft drinks, and chocolate candy to total caffeine intake was 87, 7, 5, and 1%, respectively, among regular coffee drinkers, and 18, 42, 32, and 8%, respectively, among non-regular coffee drinkers. Table 1 presents the baseline characteristics of study participants according to tea and caffeinated coffee intake. Both tea and coffee intake differed by geographic region across the United States. Tea consumption was more common in the Northeast and less so in the Midwest or West, whereas coffee consumption was more common in the West and less in the South. Women who consumed more tea were also more likely to have completed college and be nulliparous. Women who consumed more coffee were more likely to be older, currently smoke, and drink more alcohol. Frequent tea consumption was associated with a prudent dietary pattern, whereas coffee consumption was unrelated to dietary pattern.
During 555,852 person-years of follow-up, we identified 1,268 cases of breast cancer; 562 cases (44%) were premenopausal, 570 (45%) were postmenopausal, and 136 (11%) had uncertain menopausal status. Among 745 cases with known hormone receptor status, 366 (49%) were ER?/PR?, 103 (14%) were ER?/PR-, 12 (2%) were ER-/PR?, and 264 (35%) had ER-/PR-tumors. Cases with known and unknown hormone receptor status were similar with respect to tea and coffee consumption, age, education, and other lifestyle and reproductive factors.
Intakes of tea, caffeinated coffee, decaffeinated coffee, and caffeine were not associated with overall risk of breast cancer ( Table 2 ). The multivariable IRRs for C4 cups/day of tea and caffeinated coffee relative to no intake were 1.13 (95% CI 0.78-1.63) and 1.03 (95% CI 0.77-1.39), respectively. The IRR for C2 cups/day of decaffeinated coffee compared with none was 0.82 (95% CI 0.61-1.11). The IRR comparing the top to the bottom quintiles of caffeine was 1.04 (95% CI 0.87-1.24).
Tea, coffee, and caffeine consumption was not associated with breast cancer risk according to menopausal status (Table 3) . Among premenopausal women, the multivariable IRRs for C4 cups/day of tea and caffeinated coffee relative to no intake were 0.90 (95% CI 0.48-1.69) and 1.33 (95% CI 0.83-2.11), respectively, whereas the IRR for C2 cups/day of decaffeinated coffee compared with none was 0.99 (95% CI 0.56-1.72). Among postmenopausal women, the corresponding IRRs were 1.44 (95% CI 0.89-2.34), 0.85 (95% CI 0.55-1.32), and 0.93 (95% CI 0.65-1.33) for tea, caffeinated coffee, and decaffeinated coffee, respectively. The multivariable IRRs comparing the top and bottom quintiles of caffeine were 0.97 (95% CI 0.74-1.26) among premenopausal women and 1.03 (95% CI 0.79-1.34) among postmenopausal women.
When we examined the associations jointly by menopausal status and ER/PR status, results by menopausal status did not appear to differ for ER?/PR? and ER-/PR-breast cancer (Table 4) . Results are not presented for ER?/PR-or ER-/PR? breast cancer because the number of cases was too small for meaningful interpretations. 
Discussion
In this large prospective study of African-American women, intakes of tea, coffee, and caffeine were not associated with overall risk of breast cancer. There were no significant associations within categories of menopausal status or hormone receptor status. Green tea intake has been inversely associated with breast cancer risk; however, results for black tea have been mixed [8] . We did not ask about the type of tea consumed, but black tea comprises the majority of tea consumption in Western populations [23] . Our null findings are consistent with previous studies that suggest no association of black tea intake with risk of breast cancer. A meta-analysis reported an inverse association between black tea and breast cancer incidence among eight case-control studies, but five cohort studies predominantly of postmenopausal women suggested a modest increase in breast cancer risk, with a summary OR of 1.15 (95% CI 1.02-1.31) for highest vs. lowest intake [8] . A more recent analysis from the Swedish Mammography Cohort observed a significant positive association between tea and breast cancer (IRR = 1.22, 95% CI 1.05-1.42, for C2 cups/day compared with none), and the association was stronger for ER?/ PR? breast cancer [9] . No association between tea and risk of breast cancer was observed in the Nurses' Health Study [11] or in the Women's Health Study [10] . Although there was no association with breast cancer overall or with ER?/ PR? breast cancer in our study, there was a non-significant positive association of heavy tea consumption with postmenopausal breast cancer (IRR = 1.44, 95% CI 0.89-2.34, for C4 cups/day compared with none). Relatively few women frequently drank tea, and power was therefore limited for detecting a modest association. The mechanism by which tea could affect breast cancer risk is unclear. A study of postmenopausal Chinese women in Singapore reported lower plasma estrone and estradiol levels in green tea drinkers but higher levels in black tea drinkers than in non-tea drinkers [24] . An in vitro study demonstrated that tea catechins exhibited antiestrogenic effects at high concentrations but estrogenic activity at lower concentrations [25] . Green tea contains much higher concentrations of catechins than black tea [26] , and these data support findings from previous studies that observed a protective effect of green tea, but not black tea, on breast cancer risk [8, 27] . Tea intake was positively associated with prolactin levels in a study among postmenopausal women in the Rotterdam Study [28] , and the authors speculated that estrogenic effects of black tea may account for some of the protective association between tea intake and risk of coronary heart disease. However, no association between tea intake and circulating sex hormones was observed among postmenopausal women in the Nurses' Health Study, but tea intake was positively associated with follicular estradiol and follicular free estradiol levels among premenopausal women [5] . In addition to effects on estrogen metabolism, flavonoids in tea have been shown to act as antioxidants and inhibit tumor cell proliferation [3, 29] .
Epidemiologic studies of the relation between coffee and caffeine intake and breast cancer risk have also been inconsistent. A meta-analysis that included nine cohort studies reported no overall association between coffee consumption and risk of breast cancer [12] . In the Nurses' Health Study, among postmenopausal women, there was a significant inverse association with caffeine intake (IRR = 0.88, 95% CI 0.79-0.97, for the highest vs. lowest quintile) and a borderline significant inverse association with coffee (IRR = 0.89, 95% CI 0.79-1.02, for C4 cups/ day relative to none) [11] . Among postmenopausal women in our study, we observed a similar magnitude of association for coffee that was not significant (IRR = 0.85, 95% CI 0.55-1.32, for C4 cups/day relative to none), but there was no association between caffeine intake and breast cancer. Half of the women in the BWHS rarely drank coffee, and their levels of caffeine consumption from dietary sources are lower than those reported in studies comprised mostly of white women [10, 11] , among whom coffee and caffeine intake would tend to be more highly correlated than among African-American women. Studies have shown that intakes of coffee and caffeine were positively associated with sex hormone-binding globulin in postmenopausal women [5, 7] , which could explain one mechanism for an inverse association between coffee intake and risk of breast cancer [30] . Studies examining the association between coffee, caffeine, and circulating estrogens among premenopausal women have been conflicting. A study of older premenopausal women reported that caffeine was inversely associated with free estradiol [4] , and the Nurses' Health Study reported lower luteal levels of total and free estradiol with increasing coffee consumption [5] . However, one study observed that increasing coffee intake was associated with higher early follicular phase estradiol [6] . A study of premenopausal, nulliparous women reported that coffee intake was positively associated with the ratio of 2-hydroxyestrone (2-OHE1) to 16µ-hydroxyestrone (16µ-OHE1) plasma levels [31] . Evidence suggests that 2-OHE1 has lower estrogenic activity than 16µ-OHE1 and that a high 2-OHE1/16µ-OHE1 ratio may be associated with a reduced risk of breast cancer [32] [33] [34] . However, a study in a multiethnic population of premenopausal women observed higher urinary levels of both 2-OHE1 and 16µ-OHE1 with increasing caffeine consumption [35] . Coffee is also a major source of phenolic compounds, including lignans and chlorogenic acid [36, 37] . Lignans can be converted into compounds with antiestrogenic properties, and there is increasing evidence that high lignan intake is associated with a reduced risk of breast cancer [38] , whereas chlorogenic acid may influence breast cancer risk through its antioxidant capacity [39] .
Strengths of our study include its large size, prospective design, high rate and length of follow-up, information on breast cancer risk factors and other potential confounders, and focus on African-American women. We did not have validation data for coffee and tea consumption in the BWHS, but intakes of tea and coffee have been shown to be relatively well reported in other populations [40, 41] . Misclassification of long-term tea and coffee intake would likely be random and would have attenuated true associations. Tea and coffee consumption was relatively low in the BWHS, and therefore we had limited power to detect modest associations for high levels of intake. It is possible that unknown lifestyle factors may have influenced our findings, but we were able to control for several established breast cancer risk factors, which did not appreciably affect our results.
In conclusion, our results suggest that tea, coffee, and caffeine consumption is not significantly associated with risk of breast cancer among African-American women. These associations warrant further study according to both menopausal status and breast cancer subtype in populations with a wide range of tea and coffee consumption.
